{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:58:15Z","timestamp":1787507895267,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.maturitas.2024.108024","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T21:45:48Z","timestamp":1715636748000},"page":"108024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Menopause and metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1016","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9232-4042","authenticated-orcid":false,"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios G.","family":"Goulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2024.108024_bb0005","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"29","author":"Rinella","year":"2023","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.maturitas.2024.108024_bb0010","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.cmet.2024.03.011","article-title":"New and emerging treatments for metabolic dysfunction-associated steatohepatitis","volume":"36","author":"Tincopa","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.maturitas.2024.108024_bb0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cld.2015.10.010","article-title":"Progression and natural history of nonalcoholic fatty liver disease in adults","volume":"20","author":"Marengo","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.maturitas.2024.108024_bb0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.eprac.2022.10.007","article-title":"A meta-analysis on associated risk of mortality in nonalcoholic fatty liver disease","volume":"29","author":"Fu","year":"2023","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.maturitas.2024.108024_bb0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.maturitas.2024.108024_bb0030","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.maturitas.2024.108024_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2023.109330","article-title":"Navigating nonalcoholic fatty liver disease (NAFLD): exploring the roles of estrogens, pharmacological and medical interventions, and life style","volume":"203","author":"Zuo","year":"2024","journal-title":"Steroids"},{"key":"10.1016\/j.maturitas.2024.108024_bb0040","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s42000-022-00369-8","article-title":"Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease","volume":"21","author":"Polyzos","year":"2022","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.maturitas.2024.108024_bb0045","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2174\/1570161116666180711121949","article-title":"Menopause and non-alcoholic fatty liver disease: a review focusing on therapeutic perspectives","volume":"17","author":"Venetsanaki","year":"2019","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.maturitas.2024.108024_bb0050","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3390\/cells8101259","article-title":"Potential therapeutic application of estrogen in gender disparity of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"8","author":"Lee","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.maturitas.2024.108024_bb0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.23736\/S0391-1977.16.02563-3","article-title":"Adipose tissue, obesity and non-alcoholic fatty liver disease","volume":"42","author":"Polyzos","year":"2017","journal-title":"Minerva Endocrinol."},{"key":"10.1016\/j.maturitas.2024.108024_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2022.107190","article-title":"Establishment of a new nonalcoholic steatohepatitis model; Ovariectomy exacerbates nonalcoholic steatohepatitis-like pathology in diabetic rats","volume":"116","author":"Saigo","year":"2022","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.maturitas.2024.108024_bb0065","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1665-2681(19)31616-3","article-title":"Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens","volume":"9","author":"Gutierrez-Grobe","year":"2010","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.maturitas.2024.108024_bb0070","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/gut.2006.115345","article-title":"Menopausal status and hepatic steatosis in a general female population","volume":"56","author":"V\u00f6lzke","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.maturitas.2024.108024_bb0075","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa134","article-title":"NAFLD and NASH in postmenopausal women: implications for diagnosis and treatment","volume":"161","author":"DiStefano","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/j.maturitas.2024.108024_bb0080","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/GME.0000000000002133","article-title":"Menopause is associated with increased prevalence of nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"30","author":"Jaroenlapnopparat","year":"2023","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2024.108024_bb0085","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1440-1746.2005.04086.x","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults","volume":"21","author":"Park","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.maturitas.2024.108024_bb0090","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/GME.0000000000000352","article-title":"Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index","volume":"22","author":"Wang","year":"2015","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2024.108024_bb0095","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.cgh.2020.08.012","article-title":"Associations between reproductive and hormone-related factors and risk of nonalcoholic fatty liver disease in a multiethnic population","volume":"19","author":"Wang","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.maturitas.2024.108024_bb0100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12944-024-02020-4","article-title":"Association of hysterectomy with nonalcoholic fatty liver disease among US women","volume":"23","author":"Jin","year":"2024","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.maturitas.2024.108024_bb0105","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hep.26761","article-title":"Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.maturitas.2024.108024_bb0110","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/hep.27097","article-title":"The influence of menopause on the development of hepatic fibrosis in nonobese women with nonalcoholic fatty liver disease","volume":"60","author":"Yoneda","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.maturitas.2024.108024_bb0115","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MCG.0b013e31824587e0","article-title":"Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease","volume":"46","author":"Polyzos","year":"2012","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.maturitas.2024.108024_bb0120","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1002\/oby.23904","article-title":"Combining diabetes, sex, and menopause as meaningful clinical features associated with NASH and liver fibrosis in individuals with class II and III obesity: a retrospective cohort study","volume":"31","author":"Raverdy","year":"2023","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.maturitas.2024.108024_bb0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.28514","article-title":"A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease","volume":"64","author":"Klair","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.maturitas.2024.108024_bb0130","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2174\/1570161117666190405164313","article-title":"Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block","volume":"18","author":"Athyros","year":"2020","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.maturitas.2024.108024_bb0135","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/BF03401306","article-title":"Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease","volume":"12","author":"Polyzos","year":"2013","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.maturitas.2024.108024_bb0140","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s40618-022-01766-x","article-title":"Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones","volume":"45","author":"Pafili","year":"2022","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.maturitas.2024.108024_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1223162","article-title":"Association of sex hormones and sex hormone-binding globulin with liver fat in men and women: an observational and Mendelian randomization study","volume":"14","author":"Cai","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.maturitas.2024.108024_bb0150","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/er.2018-00158","article-title":"Reproductive endocrinology of nonalcoholic fatty liver disease","volume":"40","author":"Grossmann","year":"2019","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.maturitas.2024.108024_bb0155","doi-asserted-by":"crossref","first-page":"35983","DOI":"10.1074\/jbc.M507339200","article-title":"Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways","volume":"280","author":"D'Eon","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.maturitas.2024.108024_bb0160","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/db11-1718","article-title":"Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance","volume":"62","author":"Zhu","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.maturitas.2024.108024_bb0165","doi-asserted-by":"crossref","first-page":"G1031","DOI":"10.1152\/ajpgi.00211.2011","article-title":"Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet","volume":"301","author":"Kamada","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.maturitas.2024.108024_bb0170","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.3390\/antiox12122100","article-title":"17\u03b2-estradiol (E(2)) upregulates the ER\u03b1\/SIRT1\/PGC-1\u03b1 signaling pathway and protects mitochondrial function to prevent bilateral oophorectomy (OVX)-induced nonalcoholic fatty liver disease (NAFLD)","volume":"12","author":"Tian","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.maturitas.2024.108024_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e29013","article-title":"17\u03b2-estradiol protects female rats from bilateral oophorectomy-induced nonalcoholic fatty liver disease induced by improving linoleic acid metabolism alteration and gut microbiota disturbance","volume":"10","author":"Tian","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.maturitas.2024.108024_bb0180","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/gast.2002.33573","article-title":"Nonalcoholic fatty liver disease","volume":"122","author":"Clark","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.maturitas.2024.108024_bb0185","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2265.2006.02543.x","article-title":"Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial","volume":"65","author":"McKenzie","year":"2006","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.maturitas.2024.108024_bb0190","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1590\/S0004-28032013000200032","article-title":"Nonalcoholic fatty liver disease in menopausal women","volume":"50","author":"Florentino","year":"2013","journal-title":"Arq. Gastroenterol."},{"key":"10.1016\/j.maturitas.2024.108024_bb0195","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3748\/wjg.v18.i3.237","article-title":"Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women","volume":"18","author":"Hamaguchi","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.maturitas.2024.108024_bb0200","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cgh.2016.07.034","article-title":"Patient sex, reproductive status, and synthetic hormone use associate with histologic severity of nonalcoholic steatohepatitis","volume":"15","author":"Yang","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.maturitas.2024.108024_bb0205","article-title":"Different effects of menopausal hormone therapy on non-alcoholic fatty liver disease based on the route of estrogen administration","volume":"13","author":"Kim","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.maturitas.2024.108024_bb0210","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/apt.16575","article-title":"Review article: non-alcoholic fatty liver disease and cardiovascular diseases - associations and treatment considerations","volume":"54","author":"Polyzos","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.maturitas.2024.108024_bb0215","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.gme.0000218683.97338.ea","article-title":"Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis","volume":"13","author":"Atsma","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2024.108024_bb0220","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S0015-0282(01)01699-5","article-title":"Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000","volume":"75","author":"Godsland","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.maturitas.2024.108024_bb0225","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial","volume":"273","author":"Miller","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2024.108024_bb0230","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.maturitas.2020.03.007","article-title":"Menopause symptom management in women with dyslipidemias: an EMAS clinical guide","volume":"135","author":"Anagnostis","year":"2020","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2024.108024_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003100","article-title":"Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of population-based observational studies","volume":"17","author":"Jarvis","year":"2020","journal-title":"PLoS Med."},{"key":"10.1016\/j.maturitas.2024.108024_bb0240","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.maturitas.2022.08.008","article-title":"Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group","volume":"166","author":"Mendoza","year":"2022","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2024.108024_bb0245","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.maturitas.2015.02.003","article-title":"EMAS position statement: the ten point guide to the integral management of menopausal health","volume":"81","author":"Neves","year":"2015","journal-title":"Maturitas"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512224001191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512224001191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T16:39:49Z","timestamp":1718210389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512224001191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":49,"alternative-id":["S0378512224001191"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2024.108024","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Menopause and metabolic dysfunction-associated steatotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2024.108024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108024"}}